Lupin’s arm receives USFDA approval for Generic Zyvox Tablets

24 Aug 2016 Evaluate

Lupin’s US subsidiary, Gavis Pharmaceuticals LLC., U.S.A. has received final approval for its Linezolid Tablets, 600 mg from the United States Food and Drug Administration (FDA) to market a generic equivalent of Pharmacia & Upjohn Company's Zyvox Tablets, 600 mg.

Linezolid Tablets, 600 mg are the AB rated generic equivalent of Pharmacia & Upjohn Company's Zyvox Tablets, 600 mg. It is indicated in adults and children for the treatment of certain infections caused by susceptible Gram-positive bacteria. Zyvox Tablets had US sales of $ 273.6 million as per IMS MAT June 2016 data.

Lupin is an innovation led transnational pharmaceutical company producing and developing a wide range of branded & generic formulations, biotechnology products and APIs globally.

Lupin Share Price

2103.30 -8.70 (-0.41%)
01-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1720.40
Dr. Reddys Lab 1253.60
Cipla 1500.10
Zydus Lifesciences 914.50
Lupin 2103.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×